TrialEating and weight disorders : EWD2021

An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.

Elvira Anna Carbone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.